Optimi Health Corp.

Optimi Health Corp. (OPTI) priced its initial public offering on May 20, 2026 at $6.25 per share, and listed on Nasdaq Capital Market. At the IPO price its market capitalization was about $35.2M. Joseph Gunnar was lead-left underwriter. Norton Rose Fulbright advised the company.

Optimi Health Corp. is a Canadian pharmaceutical manufacturer licensed by Health Canada to handle controlled substances, producing MDMA and botanically derived psilocybin at two production facilities in Princeton, British Columbia, under a Drug Establishment Licence.

Status

IPO

Ticker

OPTI

Exchange

Nasdaq Capital Market

Priced

May 20, 2026

IPO price

$6.25

Market cap at IPO price

$35.2M

First filed

Sep 5, 2025

Underwriters

Joseph Gunnar

Company counsel

Norton Rose Fulbright

Sector

Biotech & pharma

Country / state

British Columbia, Canada

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.